1. Home
  2. RGEN vs PR Comparison

RGEN vs PR Comparison

Compare RGEN & PR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • PR
  • Stock Information
  • Founded
  • RGEN 1981
  • PR 2015
  • Country
  • RGEN United States
  • PR United States
  • Employees
  • RGEN N/A
  • PR N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • PR Oil & Gas Production
  • Sector
  • RGEN Health Care
  • PR Energy
  • Exchange
  • RGEN Nasdaq
  • PR Nasdaq
  • Market Cap
  • RGEN 8.0B
  • PR 9.5B
  • IPO Year
  • RGEN N/A
  • PR 2016
  • Fundamental
  • Price
  • RGEN $118.85
  • PR $14.74
  • Analyst Decision
  • RGEN Buy
  • PR Strong Buy
  • Analyst Count
  • RGEN 11
  • PR 16
  • Target Price
  • RGEN $172.67
  • PR $18.47
  • AVG Volume (30 Days)
  • RGEN 736.8K
  • PR 10.7M
  • Earning Date
  • RGEN 07-29-2025
  • PR 08-05-2025
  • Dividend Yield
  • RGEN N/A
  • PR 4.07%
  • EPS Growth
  • RGEN N/A
  • PR 39.99
  • EPS
  • RGEN N/A
  • PR 1.62
  • Revenue
  • RGEN $650,429,000.00
  • PR $5,134,186,000.00
  • Revenue This Year
  • RGEN $13.93
  • PR $7.10
  • Revenue Next Year
  • RGEN $14.35
  • PR $1.46
  • P/E Ratio
  • RGEN N/A
  • PR $9.08
  • Revenue Growth
  • RGEN 4.88
  • PR 37.00
  • 52 Week Low
  • RGEN $102.97
  • PR $10.01
  • 52 Week High
  • RGEN $182.52
  • PR $16.95
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 39.78
  • PR 68.95
  • Support Level
  • RGEN $120.68
  • PR $14.48
  • Resistance Level
  • RGEN $135.30
  • PR $14.94
  • Average True Range (ATR)
  • RGEN 4.93
  • PR 0.41
  • MACD
  • RGEN -0.64
  • PR 0.11
  • Stochastic Oscillator
  • RGEN 18.40
  • PR 87.40

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About PR Permian Resources Corporation

Permian Resources Corp is an independent oil and natural gas company focused on generating outsized returns to stakeholders through the responsible acquisition, optimization and development of oil and liquids-rich natural gas assets. The Company's assets and operations are concentrated in the core of the Permian Basin, and its properties consist of large, contiguous acreage blocks located in West Texas and New Mexico.

Share on Social Networks: